Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.


home / news releases / ONCT - Oncternal Therapeutics: As Phase 2 Study Matures Data Continues To Improve

ONCT - Oncternal Therapeutics: As Phase 2 Study Matures Data Continues To Improve

Oncternal Therapeutics Inc.
  • ONCT already has great data in MCL, but that data further improved as the Phase 2 study matured.
  • I parse some of the results and compare them to previous data from current standard of care ibrutinib.
  • Based on the entirety of its data, ONCT is initiating a Phase 3 MCL registrational study in the third quarter of 2022.

For further details see:

Oncternal Therapeutics: As Phase 2 Study Matures, Data Continues To Improve
Stock Information
Company Name: Oncternal Therapeutics Inc.
Stock Symbol: ONCT
Market: NASDAQ
Website: oncternal.com
Menu
ONCT ONCT Quote ONCT Short ONCT News ONCT Articles ONCT Message Board
Get ONCT Alerts

News, Short Squeeze, Breakout and More Instantly...